The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

Published:2010-12-17 Issue:1 Volume:10 Page:61-75
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Perzborn Elisabeth,Roehrig Susanne,Straub Alexander,Kubitza Dagmar,Misselwitz Frank

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.nature.com/articles/nrd3185.pdf

Reference157 articles.

1. McLean, J. The thromboplastic action of cephalin. Am. J. Physiol. 41, 250–257 (1916).

2. Hirsh, J. et al. Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133, 141S–159S (2008).

3. Warkentin, T. E., Greinacher, A., Koster, A., Lincoff, A. M. & American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133, 340S–380S (2008).

4. Warwick, D., Dahl, O. E. & Fisher, W. D. Orthopaedic thromboprophylaxis: limitations of current guidelines. J. Bone Joint Surg. Br. 90, 127–132 (2008).

5. Campbell, H. A. & Link, K. P. Studies on the hemorrhagic sweet clover disease. IV. The isolation and crystallization of the hemorrhagic agent. J. Biol. Chem. 138, 21–33 (1941).

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Determination of Rivaroxaban by Using Terahertz Metamaterial Biosensor;Photonics;2024-08-29

2. Global trends in research of venous thromboembolism associated with lower limb joint arthroplasty: A bibliometric analysis;Medicine;2024-06-21

3. Synthesis, In vitro anticancer activity and molecular docking studies on some new phenylmorpholine linked aminotetrazoles and aryl tetrazoles;Arkivoc;2024-06-09

4. The Structure-property Relationships of Clinically Approved Protease Inhibitors;Current Medicinal Chemistry;2024-04

5. ABCG2 polymorphism and rivaroxaban pharmacokinetics in healthy individuals after a single dose;Brazilian Journal of Medical and Biological Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3